Urapidil Impurity 15 | CAS 34654-80-3 - Request Quote
Urapidil Impurity 15
| SZ CAT No: | SZ-U001012 |
| CAS No | 34654-80-3 |
| Mol.F. | C9H15N3O3 |
| Mol.Wt. | 213.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Urapidil Impurity 15 is chemically 6-((3-Hydroxypropyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione. Urapidil Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Urapidil Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Urapidil .
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 34654-80-3
Purchase 34654-80-3
Order 34654-80-3
Enquire 34654-80-3
price of 34654-80-3
34654-80-3 Supplier
34654-80-3 Manufacturer
34654-80-3 Exporter
buy high quality Urapidil Impurity 15
Purchase Urapidil Impurity 15
Urapidil Impurity 15 suppliers
Urapidil Impurity 15 manufacturers
Urapidil Impurity 15 price
Order Urapidil Impurity 15
Enquire Urapidil Impurity 15
Urapidil Impurity 15 cost
Urapidil Impurity 15 Supplier
Urapidil Impurity 15 Distributor
Urapidil Impurity 15 for Method Validation
Urapidil Reference Standard
Urapidil Impurity 15 for ANDA Filing
Urapidil Impurity 15 for Forced Degradation Studies
Urapidil Impurity 15 Identification Standards
Urapidil Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


